INMED PHARMACEUTICALS INC (INM)

CA4576376012 - Common Stock

0.364  +0.02 (+4.96%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023
Revenue
YoY % growth
1.09M4.14M
279.82%
EBITDA
YoY % growth
-9.82M
-8.63%
-13.4M
-36.46%
-8.18M
38.96%
EBIT
YoY % growth
-9.94M
-8.63%
-13.59M
-36.72%
-8.38M
38.34%
Operating Margin
N/A-1,246.79%-202.42%
EPS
YoY % growth
N/A-34.28N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
-14.03
-36.88%
-5.56-8.48-152.57%
Q3 2022
Q2Q % growth
-6.25
39.02%
-6.310.060.99%
Q2 2022
Q2Q % growth
-7.75
24.39%
-5.93-1.82-30.61%
Q1 2022
Q2Q % growth
-6.25
-1,424.39%
-8.842.5929.28%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
510K
∞%
757.5K-247.5K-32.67%
Q3 2022
Q2Q % growth
310K
∞%
606K-296K-48.84%
Q2 2022
Q2Q % growth
270K
∞%
126.25K143.75K113.86%
Q1 2022
Q2Q % growth
252.5K-252.5K-100.00%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A